Atlas Trials

Intermittent or Continuous Acetylsalicylic Acid and Gene Expression in the Nasal Tissue of Current Smokers

Clinical trial NCT02123849 · COMPLETED

Trial details

NCT number
NCT02123849
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Lung CarcinomaTobacco Use Disorder
Start date
2014-06-01
Primary completion
2016-09-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.